$91.40 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About DexCom

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.

Stock Analysis

last close $89.09
1-mo return 13.5%
3-mo return -6%
avg daily vol. 2.74M
52-week high 164.86
52-week low 66.89
market cap. $35.0B
forward pe 90.5
annual div. -
roe 9.4%
ltg forecast 31.4%
dividend yield -
annual rev. $2.7B
inst own. 98.4%

Subscribe now for daily local and international financial news